As of 2025-08-02, the Intrinsic Value of Imugene Ltd (IMU.AX) is -2.00 AUD. This IMU.AX valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.25 AUD, the upside of Imugene Ltd is -900.36%.
Based on its market price of 0.25 AUD and our intrinsic valuation, Imugene Ltd (IMU.AX) is overvalued by 900.36%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.00 - -2.00 | -2.00 | -900.36% |
| P/E | (2.71) - (3.87) | (3.33) | -1432.6% |
| DDM - Stable | (2.89) - (8.00) | (5.44) | -2277.9% |
| DDM - Multi | (2.98) - (6.53) | (4.10) | -1740.6% |
| Market Cap (mil) | 80.78 |
| Beta | 0.99 |
| Outstanding shares (mil) | 323.12 |
| Enterprise Value (mil) | 61.77 |
| Market risk premium | 5.10% |
| Cost of Equity | 11.10% |
| Cost of Debt | 5.00% |
| WACC | 10.98% |